Due to ongoing manufacturing issues, Norpace CR continues to be in short supply with normal resupply not expected until 2018. Currently, only Norpace CR 100mg in 100-count bottles is available (NDC# 0025-2732-31) through drop shipment; Norpace CR 100mg (500-count bottles), and Norpace CR 150mg (100-count and 500-count bottles) are not available and are on backorder.
Norpace CR is a Type 1 antiarrhythmic drug indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgement of the physician, are life-threatening. Because of the proarrhythmic effects of the drug, its use with lesser arrhythmias is generally not recommended.
Norpace (disopyramide phosphate capsules) is not affected by this manufacturing event.
For more information visit FDA.gov.